These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9146665)

  • 1. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells.
    Ferrer FA; Miller LJ; Andrawis RI; Kurtzman SH; Albertsen PC; Laudone VP; Kreutzer DL
    J Urol; 1997 Jun; 157(6):2329-33. PubMed ID: 9146665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells.
    Ferrer FA; Miller LJ; Andrawis RI; Kurtzman SH; Albertsen PC; Laudone VP; Kreutzer DL
    Urology; 1998 Jan; 51(1):161-7. PubMed ID: 9457313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia.
    Jackson MW; Bentel JM; Tilley WD
    J Urol; 1997 Jun; 157(6):2323-8. PubMed ID: 9146664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.
    Balbay MD; Pettaway CA; Kuniyasu H; Inoue K; Ramirez E; Li E; Fidler IJ; Dinney CP
    Clin Cancer Res; 1999 Apr; 5(4):783-9. PubMed ID: 10213213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
    Ravindranath N; Wion D; Brachet P; Djakiew D
    J Androl; 2001; 22(3):432-43. PubMed ID: 11330643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB; Isaacs JT
    Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting.
    Borre M; Nerstrøm B; Overgaard J
    Clin Cancer Res; 2000 May; 6(5):1882-90. PubMed ID: 10815911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer.
    West AF; O'Donnell M; Charlton RG; Neal DE; Leung HY
    Br J Cancer; 2001 Aug; 85(4):576-83. PubMed ID: 11506499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
    Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.
    Woessner RD; Wright PS; Loudy DE; Wallace CD; Montgomery LR; Nestok BR
    Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor Flk-1 in benign, premalignant, and malignant prostate tissue.
    Köllermann J; Helpap B
    Am J Clin Pathol; 2001 Jul; 116(1):115-21. PubMed ID: 11447740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells.
    Chen HJ; Treweeke AT; Ke YQ; West DC; Toh CH
    Br J Cancer; 2000 May; 82(10):1694-701. PubMed ID: 10817506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor.
    Yu A; Somasundar P; Balsubramaniam A; Rose AT; Vona-Davis L; McFadden DW
    J Surg Res; 2002 Jun; 105(1):65-8. PubMed ID: 12069504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model.
    Melnyk O; Zimmerman M; Kim KJ; Shuman M
    J Urol; 1999 Mar; 161(3):960-3. PubMed ID: 10022734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of vascular endothelial growth factor (VEGF) in prostate disease.
    Walsh K; Sriprasad S; Hopster D; Codd J; Mulvin D
    Prostate Cancer Prostatic Dis; 2002; 5(2):119-22. PubMed ID: 12497000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor-A in human lymph node metastases of prostate cancer.
    Ismail AH; Altaweel W; Chevalier S; Kassouf W; Aprikian AG
    Can J Urol; 2004 Feb; 11(1):2146-50. PubMed ID: 15003156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression.
    Deroanne CF; Hajitou A; Calberg-Bacq CM; Nusgens BV; Lapière CM
    Cancer Res; 1997 Dec; 57(24):5590-7. PubMed ID: 9407972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.